Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398873
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-04-25
Brief Title:
Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Organization Data
Organization:
Medical University of Vienna
Class:
OTHER
Study ID:
EpiBar
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of Vienna
Lead Sponsor Class:
OTHER
Responsible Party:
Sven Schneider MD
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Medical University of Vienna
Old Name:
None
Old Organization:
None